Chordoma is a rare type of cancer that develops in the bones of the skull base and spine. It arises from remnants of the notochord, a structure present during early embryonic development. While chordoma is a relatively uncommon condition, it has affected individuals from all walks of life, including some well-known celebrities.
Steve Jobs, the co-founder of Apple Inc., was diagnosed with chordoma in 2003. He initially experienced back pain, which led to the discovery of a tumor at the base of his skull. Despite undergoing various treatments, including surgery and radiation therapy, Jobs' condition worsened over time. He passed away in 2011, leaving behind a remarkable legacy in the world of technology.
Yul Brynner, a renowned actor best known for his role as the King of Siam in "The King and I," was also afflicted by chordoma. He was diagnosed in 1983 and underwent multiple surgeries to remove the tumor. Brynner used his celebrity status to raise awareness about the disease before his death in 1985.
Josh Sommer, although not a celebrity in the traditional sense, became a prominent figure in the chordoma community. He was diagnosed with the disease at the age of 18 while attending college. Sommer co-founded the Chordoma Foundation, a non-profit organization dedicated to accelerating research and finding a cure for chordoma. His advocacy and efforts have significantly contributed to advancements in chordoma research and treatment.
Michael Weiner, also known as Michael Savage, is a well-known conservative radio host and author. In 2018, he revealed that he had been battling chordoma for over a year. Weiner underwent extensive treatment, including surgery and radiation therapy, and continues to raise awareness about the disease through his platform.
John Preskill, a renowned theoretical physicist and professor at the California Institute of Technology, was diagnosed with chordoma in 2016. He has been actively involved in chordoma research and has shared his personal experiences with the disease. Preskill's contributions to the scientific community and his advocacy for chordoma awareness have been invaluable.
These individuals, along with many others, have faced the challenges posed by chordoma with courage and determination. Their stories have helped raise awareness about this rare cancer and have inspired efforts to improve diagnosis, treatment, and support for those affected by the disease.